Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Study of Clinicopathological Profile of Sporadic Cases of Colorectal Cancer.

Saha M, Shil BC, Saha SK, Banik RK, Perveen I, Chowdhury MS, Islam AN, Saifullah A.

Euroasian J Hepatogastroenterol. 2016 Jul-Dec;6(2):134-136. doi: 10.5005/jp-journals-10018-1185. Epub 2016 Dec 1.

2.

Alleviating Promotion of Inflammation and Cancer Induced by Nonsteroidal Anti-Inflammatory Drugs.

Kyriakopoulos AM, Nagl M, Baliou S, Zoumpourlis V.

Int J Inflam. 2017;2017:9632018. doi: 10.1155/2017/9632018. Epub 2017 May 10. Review.

3.

Disparities Between Blacks and Whites in Stage at Diagnosis, Incidence, and Anatomic Subsite of Colorectal Cancer.

Hobley J, Lengerich EJ, Lindsay Ii JA, McGarrity TJ.

Gastroenterol Hepatol (N Y). 2006 Jul;2(7):498-502.

4.

Gender, aging and longevity in humans: an update of an intriguing/neglected scenario paving the way to a gender-specific medicine.

Ostan R, Monti D, Gueresi P, Bussolotto M, Franceschi C, Baggio G.

Clin Sci (Lond). 2016 Oct 1;130(19):1711-25. doi: 10.1042/CS20160004. Review.

5.

The Role of Stage at Diagnosis in Colorectal Cancer Black-White Survival Disparities: A Counterfactual Causal Inference Approach.

Valeri L, Chen JT, Garcia-Albeniz X, Krieger N, VanderWeele TJ, Coull BA.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):83-9. doi: 10.1158/1055-9965.EPI-15-0456. Epub 2015 Oct 26.

6.

Different prognostic effect of CpG island methylation according to sex in colorectal cancer patients treated with adjuvant FOLFOX.

Lee DW, Han SW, Cha Y, Rhee YY, Bae JM, Cho NY, Lee KH, Kim TY, Oh DY, Im SA, Bang YJ, Jeong SY, Park KJ, Kang GH, Kim TY.

Clin Epigenetics. 2015 Jul 9;7:63. doi: 10.1186/s13148-015-0106-0. eCollection 2015.

7.

Clinical impact of endoscopy position detecting unit (UPD-3) for a non-sedated colonoscopy.

Fukuzawa M, Uematsu J, Kono S, Suzuki S, Sato T, Yagi N, Tsuji Y, Yagi K, Kusano C, Gotoda T, Kawai T, Moriyasu F.

World J Gastroenterol. 2015 Apr 28;21(16):4903-10. doi: 10.3748/wjg.v21.i16.4903.

8.

LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.

Lou YT, Chen CW, Fan YC, Chang WC, Lu CY, Wu IC, Hsu WH, Huang CW, Wang JY.

PLoS One. 2015 Apr 28;10(4):e0123973. doi: 10.1371/journal.pone.0123973. eCollection 2014.

9.

Associations of census-tract poverty with subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis in the United States.

Henry KA, Sherman RL, McDonald K, Johnson CJ, Lin G, Stroup AM, Boscoe FP.

J Cancer Epidemiol. 2014;2014:823484. doi: 10.1155/2014/823484. Epub 2014 Aug 3.

10.

Does the prognosis of colorectal cancer vary with tumor site?

Jafarabadi MA, Mohammadi SM, Hajizadeh E, Kazemnejad A, Fatemi SR.

Gastroenterol Hepatol Bed Bench. 2011 Fall;4(4):199-209.

11.

Clinical features and prognosis in colorectal cancer patients with different ethnicities in Northwest China.

Yusup A, Wang HJ, Rahmutula A, Sayim P, Zhao ZL, Zhang GQ.

World J Gastroenterol. 2013 Nov 7;19(41):7183-8. doi: 10.3748/wjg.v19.i41.7183.

12.

Factors associated with the risk of adenoma recurrence in distal and proximal colon.

Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Marcus PM, Schoen RE, Lanza E, Cross AJ.

Digestion. 2013;87(3):141-6. doi: 10.1159/000346281. Epub 2013 Mar 15.

13.

Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome.

Purim O, Gordon N, Brenner B.

Med Sci Monit. 2013 Mar 20;19:203-9. doi: 10.12659/MSM.883842.

14.

Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs.

Corley DA, Jensen CD, Marks AR, Zhao WK, de Boer J, Levin TR, Doubeni C, Fireman BH, Quesenberry CP.

Clin Gastroenterol Hepatol. 2013 Feb;11(2):172-80. doi: 10.1016/j.cgh.2012.09.010. Epub 2012 Sep 14.

15.

Association of the DNMT3A -448A>G polymorphism with genetic susceptibility to colorectal cancer.

Zhao Z, Li C, Song Y, Wu Q, Qiao F, Fan H.

Oncol Lett. 2012 Feb;3(2):450-454. Epub 2011 Nov 17.

16.

Bin1 attenuation suppresses experimental colitis by enforcing intestinal barrier function.

Chang MY, Boulden J, Valenzano MC, Soler AP, Muller AJ, Mullin JM, Prendergast GC.

Dig Dis Sci. 2012 Jul;57(7):1813-21. doi: 10.1007/s10620-012-2147-y. Epub 2012 Apr 18.

17.

Development and progression of colorectal neoplasia.

Manne U, Shanmugam C, Katkoori VR, Bumpers HL, Grizzle WE.

Cancer Biomark. 2010;9(1-6):235-65. doi: 10.3233/CBM-2011-0160. Review.

18.

Recent advances in the management of carcinoma of the rectum.

Basu S, Srivastava V, Shukla VK.

Clin Exp Gastroenterol. 2009;2:49-60. Epub 2009 Jun 10.

19.

Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.

Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ.

Am J Gastroenterol. 2011 Jul;106(7):1340-50. doi: 10.1038/ajg.2011.38. Epub 2011 Mar 15.

20.

Intake of polyunsaturated fatty acids and distal large bowel cancer risk in whites and African Americans.

Kim S, Sandler DP, Galanko J, Martin C, Sandler RS.

Am J Epidemiol. 2010 May 1;171(9):969-79. doi: 10.1093/aje/kwq032. Epub 2010 Apr 14.

Supplemental Content

Support Center